- Home
- DRVN vs HCM Comparison
DRVN vs HCM Comparison
Compare DRVN & HCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DRVN | HCM |
|---|---|---|
| Founded | 1972 | 2000 |
| Country | United States | Hong Kong |
| Employees | N/A | 1796 |
| Industry | Automotive Aftermarket | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.3B |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | DRVN | HCM |
|---|---|---|
| Price | $13.05 | $10.82 |
| Analyst Decision | Buy | Sell |
| Analyst Count | 8 | 1 |
| Target Price | ★ $18.33 | $13.75 |
| AVG Volume (30 Days) | ★ 1.5M | 49.3K |
| Earning Date | 05-12-2026 | 03-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 146.70 | N/A |
| EPS | ★ 0.85 | N/A |
| Revenue | ★ $1,862,438,000.00 | N/A |
| Revenue This Year | N/A | $20.60 |
| Revenue Next Year | $1.53 | $15.62 |
| P/E Ratio | $15.16 | ★ $5.49 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $9.80 | $11.00 |
| 52 Week High | $19.74 | $19.50 |
Technical Indicators
Market Signals| Indicator | DRVN | HCM |
|---|---|---|
| Relative Strength Index (RSI) | 47.11 | 21.10 |
| Support Level | $12.49 | N/A |
| Resistance Level | $13.54 | $15.59 |
| Average True Range (ATR) | 0.59 | 0.37 |
| MACD | -0.11 | -0.02 |
| Stochastic Oscillator | 27.69 | 5.93 |
Price Performance
Historical ComparisonAbout DRVN Driven Brands Holdings Inc.
Driven Brands Holdings Inc is an automotive services company in North America. Its platform provides high-quality services to an extensive range of retail and commercial customers. The company provides an extensive range of core consumer and commercial automotive needs, including paint, collision, glass, and repair services, as well as a variety of high-frequency services, such as oil changes and car washes. The company segments include: Maintenance, Car Wash, Paint, Collision & Glass, and Platform Services. It derives maximum revenue from Maintenance Segment. Geographically, the company operates into United States, Canada and Rest of the World.
About HCM HUTCHMED (China) Limited
HUTCHMED (China) Ltd is a biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies world-wide and an extensive commercial infrastructure in its home market, China. The company operates in two reportable segments: Oncology/Immunology and Other Ventures.